<DOC>
	<DOCNO>NCT01078935</DOCNO>
	<brief_summary>Fifty patient get probiotic ( 109 bacteria [ L. acidophilus , B. bifidum , S. thermophilus , L. rhamnosus , L. casei ] 2 capsule ) half get placebo ( 2 capsule look like probiotic capsule contain microcrystalline cellulose , artificial brown color , magnesium strearate , silica dioxide ) . The patient staff blind identity study medication . Each patient volunteer get study medication 6 week evaluate twice - enrollment 6 week treatment . Routine clinical management continue - regular treatment need . Each individual study change biochemical inflammatory immunological marker change flow medicate diameter measure brachial artery method ( evaluate endothelial function ) . Every patient evaluate his/her ability produce endothelial progenitor stem cell ( EPCs ) .</brief_summary>
	<brief_title>The Effect Probiotics Rate Recovery Inflammatory Bowel Disease Exacerbation , Endothelial Function , Markers Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>patient ulcerative colitis crohn ' disease . notable caveat arteries small 2.5 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Crohn 's disease activity index</keyword>
	<keyword>CDAI</keyword>
</DOC>